Mashup Score:1
event.on24.comLeading voices on COVID-19 and the forward | Health Equity and COVID-19 - 1 day
Mashup Score:1
Twitter Feed: Deloitte Health Care
Registration - 1 day
Adverse Event (AE) collection, assessment and reporting is a foundational activity of Sanofi’s pharmacovigilance and license to operate. With over 600,000 AE cases expected...
-
Listen to Sanofi and Deloitte explain the significant operational and scientific benefits of automating adverse event case processing. Register for our safety webinar on May 4 at 11am ET! https://t.co/04lUTyPJOj - view on twitter
Accounting guidance for the life sciences industry that every biotech and pharmaceutical accounting department should know—explore our new...
-
As R&D arrangements become more complex, so are the accounting requirements and considerations. Explore our 2021 #LifeSciences Industry Accounting Guide for insights. https://t.co/dQwfdg10Ib - view on twitter
More coverage:
#lifesciences
As the industry rebuilds from the pandemic, health care organizations have an opportunity to reduce waste and make health care more...
-
#HealthPlans and health care organizations can thrive postpandemic—and make services more affordable—by reducing waste. Learn how in the #HealthForward blog. https://t.co/RYLXgYAcGm - view on twitter
Deloitte insights from health system leaders on how they’re adopting consumer health technology to improve...
-
We recently interviewed #Tech, digital, and marketing executives from 10 major health systems to understand their approach to #Consumer-facing technology. Read what we heard. https://t.co/OrAaam07kZ - view on twitter
Lt Gen (Ret) C. Bruce Green MD, MPH Managing Director Deloitte Consulting LLP Dr. Green is a veteran with 34 years of service in...
-
Hear what some of the brightest minds in #publichealth had to say about strategies to help your organization recover and move forward from #COVID19. Register and watch our webcast here! https://t.co/40PMvuOQ46 https://t.co/40PMvuOQ46 - view on twitter
Consumers may appreciate pharma companies’ efforts to speed up the process of bringing COVID-19 vaccines to market. How might biopharma continue to innovate while...
-
How can #biopharma companies continue to build trust? ✅ Proactive communication ✅ Simplifying complex science ✅ Developing patient partnerships Learn more in our latest report. https://t.co/9WwoG5hJpV - view on twitter
More coverage:
#biopharma
Join us as we convene the brightest minds in life sciences, health care, and public health in a conversation about coming together to emerge...
Catch some of the brightest minds in #healthcare and #publichealth discuss the #COVID19 pandemic through the lens of #healthequity. Register and watch here! https://t.co/HntNpEPpO0 https://t.co/HntNpEPpO0 - view on twitter